Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Colonic Neoplasms × camrelizumab × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Gastric Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Immune Checkpoint Inhibition 1 ESCC 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Bites and Stings 1 Advanced Hepatocellular Carcinoma 1

Interventions

Colonoscopy 19 Early Intervention, Educational 15 Counseling 13 Methods 10 Exercise 10 Oxaliplatin 8 Laparoscopy 8 Preoperative Exercise 7 Blood Specimen Collection 7 Therapeutics 6 Surveys and Questionnaires 5 Standard of Care 5 Saline Solution 5 Psychiatric Rehabilitation 5 Propofol 5 Patient Navigation 5 Magnetic Resonance Imaging 5 Leucovorin 5 Fluorouracil 5 Chemotherapy, Adjuvant 5 Occult Blood 4 Magnetic Resonance Spectroscopy 4 Folfox protocol 4 Diet 4 Cholecalciferol 4 Yoga 3 Sevoflurane 3 Resistance Training 3 Radiotherapy 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06215677 2025-09-05

NITDC

Peking Union Medical College Hospital

Phase NA Recruiting

Gastrointestinal

Turcot syndrome, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡